Published: July 2022 | Report Code: 12395 | Available Format: PDF
The global endoscope reprocessing market size stood at $1,879.9 million in 2021, which is expected to reach $4,358.1 million by 2030, advancing at a CAGR of 9.8% during 2021–2030. This is mainly ascribed to the rising inclination toward minimally invasive procedures, the promulgating risk of various infections associated with contaminated endoscopes, and the surging stringent government regulations spanning all over the world to regulate these infections.
The high-level disinfectants and test strips category accounted for around 35% of the market share in 2021, attributed to the rising prevalence of various endogenous infections, such as pneumonia and bacteremia, after the use of endoscopy procedures.
Similarly, the adoption of test strips is also increasing for the effective measurement of minimum effective concentration (MEC) required for high-level disinfection, thereby providing faster disinfection reaction time. In addition, it assists in the detection of residual proteins, carbohydrates, and hemoglobin on both flexible and rigid endoscopes, through the color comparison chart.
During the historical period, North America led the high-level disinfectants and test strips market, with around 50% revenue share in 2021. The region will account for the largest market share in the coming years as well, mainly due to the presence of a large number of high-level disinfectants and test strips manufacturers, stringent government regulations for keeping endoscopes sterilized after every use, high healthcare expenditure, and rise in the number of hospitals.
The automated endoscope reprocessor (AER) category is expected to register the highest CAGR, of around 12%, in the forecast period, owing to the rising number of endoscopic surgeries and the surging adoption of AERs in hospitals and ambulatory surgical centers. Moreover, companies are actively involved in launching innovative and advanced AERs in the market. For instance, in October 2020, Olympus Corporation launched OER-Elite AER for cleaning and reprocessing endoscopes. The OER-Elite can disinfect two endoscopes in less than 28 minutes.
In addition, several efforts put by government organizations to support the adoption of AERs in the region also enhance the endoscope reprocessing market growth. For instance, the FDA regulates all the critical factors that are necessary while reprocessing various endoscopes to mitigate the spread of infections. Also, as per the FDA guidelines, the AER manufacturers must provide validation testing data.
Endoscope reprocessing is predominantly used in flexible endoscopes, leading to a higher revenue share of around 65.0% in 2021 in the market. This is because prominent players in the market are actively launching AERs that are highly compatible with flexible endoscopes. For instance, approximately 90% of companies are developing AERs for flexible endoscopes, due to their feasibility to control and lighter weight. In October 2021, FUJIFILM Corporation announced the launch of the El-740D/S flexible endoscope, which is the only dual-channel flexible endoscope approved by the FDA for upper as well as lower gastrointestinal use.
Amongst the flexible type, upper gastrointestinal endoscopes and colonoscopes together account for more than 50% share in the market. This is ascribed to the promulgating incidents of GI as well colon diseases, leading to the rise in the number of hospital visits. For instance, around 40 million patients in the U.S. who visits physicians’ office are suffering from digestive system disorders.
Amongst the rigid type, laparoscopes accounted for more than 40% of the endoscope reprocessing market share in 2021, owing to the rising inclination toward minimally invasive procedures coupled with several benefits such as very few postoperative complications and faster recovery in comparison to open surgeries. These factors are leading to the high preference for laparoscopy alternatives to laparotomy. For instance, approximately 15 million laparoscopies are performed globally, every year.
Report Attribute | Details |
Historical Years |
2017-2021 |
Forecast Years |
2022-2030 |
Market Size in 2021 |
$1,879.9 Million |
Revenue Forecast in 2030 |
$4,358.1 Million |
Growth Rate |
9.8% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Regulatory Scenario; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Product, By Type, By End User, By Region |
Explore more about this report - Request free sample pages
The hospitals category is expected to record the highest CAGR, of around 11%, in the market during the forecast period. This can be attributed to the rising number of endoscopy procedures coupled with the increasing number of hospitals all over the world, and the promulgation of funds and investments provided by government bodies. For instance, the Indian government augmented its healthcare expenditure to around 1.8% of its GDP in 2021–2022, which was around 1.5% in 2020–2021.
End users in the market are becoming more inclined toward entering into comprehensive contracts with ISOs, in order to reduce complexities and additional expenses associated with separate services provided under agreements with manufacturers of medical equipment. For instance, NovaMed Corporation runs a comprehensive service management program that allows customers to consolidate the company’s services into one contract. The contract offers a cost-effective alternative to OEM contracts, coupled with multi-vendor, multi-modality access. Such examples affirm that the adoption of comprehensive endoscope service contracts is increasing.
In 2021, North America accounted for the highest revenue, of around $1.0 billion, in the market. This is attributed to the rise in preference for minimally invasive procedures, spur in cancer cases, and favorable reimbursement scenarios in the region. Moreover, the presence of giant manufacturers of medical devices, such as Boston Scientific Corporation, Stryker Corporation, Conmed Corporation, and Cantel Medical Corp., leads to the easy availability of not only endoscopes but also OEM repair services.
Whereas, the APAC market is expected to register the highest CAGR, over 10.0%, in the forecast period, due to the increase in the number of endoscopic surgeries and the improvement in healthcare infrastructure. Furthermore, Japan and China collectively accounted for around 50% share of the regional market in 2021. This is ascribed to the high incidence of GI-related cancers in both countries. For instance, as per a government organization, there were around 3,00,000 GI-related cancer deaths in China in 2021, which accounted for more than 13% of all cancer-related deaths in the nation.
In recent years, players in the endoscope reprocessing market have been involved in product launches and partnerships to attain a significant position. For instance, in September 2021, Steelco S.p.A announced the launch of EW 1 S MAXI, to increase safety, efficiency, and ease of use in the endoscope reprocessing practices.
The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.
Based on Product
Based on Type
Based on End User
Geographical Analysis
The endoscope reprocessing market size stood at $1,879.9 million in 2021.
During 2021–2030, the growth rate of the endoscope reprocessing market will be around 9.8%.
Hospitals are the largest end users in the endoscope reprocessing market.
The major drivers of the endoscope reprocessing market include the surging implementation of minimally invasive surgeries (MISs) and the increasing risk of various infections associated with contaminated endoscopes.
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws